AMGEN 16/26AMGEN 16/26AMGEN 16/26

AMGEN 16/26

No trades
See on Supercharts

AMGN analysis



Key facts


Issue date
Feb 25, 2016
Maturity date
Feb 25, 2026
Outstanding amount
‪750.00 M‬EUR
Face value
1,000.00EUR
Minimum denomination
100,000.00EUR
Coupon
2.00% (Fixed)
Yield to maturity
2.70%
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.